You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
An initial analysis suggests the Pfizer-BioNTech vaccine could reduce viral load, the Guardian reports.
A new study lends credence to the idea that pre-existing anti-cancer immunity depends heavily on patients' genetic background, according to one of the researchers.
News items for the week of Feb. 1, 2021.
The Israeli company, which specializes in informatics and AI for agricultural and livestock genomics, is trading on the Tel Aviv Stock Exchange.
Researchers profiled the transcriptomes of more than 500,000 single cells from human fetal skin and adult skin with atopic dermatitis and psoriasis.
OncoHost will use the funding to finance clinical trials, open a US location, and prepare to launch its proteomics platform called Prophet.
According to Retraction Watch, Nature Communications has retracted a highly criticized article on mentorship.
The companies are joining BioView's Duet imaging system with Ruby Nanomed's Rubychip microfluidic device for circulating tumor cell isolation.
In PNAS this week: variants in Bloom syndrome-related gene increase mesothelioma risk, Streptococcus host transcriptome atlas, and more.
In PLOS this week: investigation of pleiotropic effects using GWAS data, transcriptomic study of mosquitoes that spread Rift Valley fever, and more.
NPR reports that researchers have developed chimeric embryos as part of work toward growing human organs in animals for organ transplants.
According to the Washington Post, the Biden Administration is set to make changes to federal restrictions on fetal tissue research.
In Science this week: approach to isolated trace DNA from archaic humans from sediments, and more.
Texas Monthly looks into the DNA Zoo being collected by Baylor College of Medicine researchers.